Lorena Raquel Lerner, Chief Science Officer at Keros Therapeutics, Inc. (KROS), sold 3,873 shares at $16.35 ($63K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Open-market sale of $63k KROS by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.